戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 etween gene transcript levels and HLA ligand presentation.
2  characterized by a highly variable clinical presentation.
3 virus was detected in the CSF at the time of presentation.
4 n activity during the unimodal A (but not V) presentation.
5 at the time of the patient's initial disease presentation.
6 ns to target antigens with ultra-low surface presentation.
7  circulating biomarkers measured at hospital presentation.
8 tion, enriched for IFN signaling and antigen presentation.
9 nting with acute cSAH and 97 without cSAH at presentation.
10 e they usually require amphetamine for their presentation.
11 gens in the context of CD1d-mediated antigen presentation.
12 rum of this gene and the associated clinical presentation.
13 (SNAP and DETA-NONOate) inhibited DC antigen presentation.
14 yndrome, which shows disparities in clinical presentation.
15 c and nonhemorrhagic groups based on initial presentation.
16 possible' bvFTD diagnostic criteria at first presentation.
17 nd standard-sensitivity cTn were measured at presentation.
18 ng various organs and has a diverse clinical presentation.
19 in females compared to males during stimulus presentation.
20 igrating have been activated towards antigen presentation.
21 , if modified in people, might alter disease presentation.
22 impairment in fear memory extinction to tone presentation.
23 CC patients were categorized by MC status at presentation.
24 ents with a m.3243 A > G negative MELAS-like presentation.
25 ticulum-phagosome traffic required for cross-presentation.
26  was already present in 62 patients at first presentation.
27  disease, but substantially modifies disease presentation.
28 eurosurgical patients during visual stimulus presentation.
29 lly learning the rules of endogenous antigen presentation.
30 nterferons and hence enhances tumour antigen presentation.
31 ure that subjects have control over stimulus presentation.
32 lecule H2-O, a negative regulator of antigen presentation.
33 anage repeat patients or more complicated TB presentations.
34 cobacteria and have autoinflammatory disease presentations.
35  to minimally symptomatic or non-symptomatic presentations.
36 A interference (RNAi) in both early and late presentations.
37 fluence of contrast was strongest with brief presentations.
38  characteristic clinical and histopathologic presentations.
39                         Bleeding was rare at presentation (5%) and manifested subsequently in fewer t
40                                         CASE PRESENTATION: A 22-year-old African gentleman presented
41                                         CASE PRESENTATION: A 31-year-old woman was referred with repe
42                                         CASE PRESENTATION: A 38-year-old previously healthy woman pre
43                                         CASE PRESENTATION: A 50 year male presented with acute onset
44                                         CASE PRESENTATION: A 52 year-old diabetic woman collapsed at
45                                         CASE PRESENTATION: A 55 year old gentleman was diagnosed with
46                      On univariate analysis, presentation age, foveal retinoblastoma (at initial exam
47                            However, stimulus presentation alone does not affect primary visual cortex
48 ing expression of genes required for antigen presentation along with those for T cell tolerance.
49  CI 1.11-1.38) in children with diarrhoea at presentation and 1.76 (1.47-2.11) in children without di
50  sepsis and septic shock patients at initial presentation and 2) determine the association between ti
51 a combination of both time-dependent antigen presentation and a novel mechanism through which IL-12 a
52 A is highly variable and depends on clinical presentation and anatomic location.
53 impaired fetal growth, preterm birth, breech presentation and cesarean section were associated with a
54   Substantial overlap exists in the clinical presentation and comorbidities among patients with Middl
55 ecretory granules for antigen processing and presentation and creating a feed-forward loop of T-cell-
56                                        Cross-presentation and crosspriming depend not only on TLR9, b
57 ignificantly enhanced antigen-specific cross-presentation and cytotoxic T lymphocyte (CTL) activity.
58 rial spike count variability during stimulus presentation and decision formation.
59 ade by the combination of a typical clinical presentation and evidence of nut specifc IgE shown by a
60 ed to the individual patient on the basis of presentation and hemodynamic conditions may be beneficia
61 enging due to the highly variable phenotypic presentation and limited correlation has been identified
62                     To describe the clinical presentation and outcomes of patients with ICU-necessita
63 lement activation, can modulate both antigen presentation and T cell priming, ultimately leading to a
64 uppressed CD23-mediated facilitated allergen presentation and Th2 cytokine production.
65    We show that MCs adapt to continuous odor presentation and that mixture responses are different wh
66 osition, which has an impact on the clinical presentation and the underlying disease that triggers cr
67 the consecutive NAION event based on initial presentation and to compare mean visual loss of firstly
68                       ENIGMA-Viewer supports presentations and communications of brain research resul
69 44, 69] vs 70 [52, 78]; p < 0.001), clinical presentations and comorbidities overlapped substantially
70 r integrating themes emerged across workshop presentations and discussion and centered on 1) physiolo
71      The meeting included formative didactic presentations and facilitated breakout discussions using
72          Primary outcomes were repeat clinic presentations and growth over 24 wk.
73               P-SCAD patients had more acute presentations and high-risk features than women with NP-
74                                 The workshop presentations and panel discussions focused on current u
75  and not just reserved for those with severe presentations and poor outcomes.
76 ctome visualizations for users' own research presentations and publications.
77 R) Country Operational Plans, and conference presentations and/or abstracts for the latest available
78 edian of 4.4 years, many from first clinical presentation, and 106 scans of 80 healthy paediatric par
79 iation dose, bilateral ocular involvement at presentation, and advanced stage were significantly corr
80 egradation, cholesterol homeostasis, antigen presentation, and cell invasion.
81              Demographics, clinical history, presentation, and in-hospital treatments were compared b
82 the molecular basis that governs the antigen presentation, and the interactions between antigens and
83   Hazard rates of AT across lifetime, age at presentation, and the time lapse between surgery and the
84 s suggesting that other mechanism of antigen presentation are driving the robust T cell response obse
85 utive caspase-1 activation, their phenotypic presentations are different, implying that these mutatio
86 across a spectrum of coronary artery disease presentations are warranted.
87  a cardiac troponin I threshold of 5 ng/L at presentation as a risk stratification tool in patients w
88                           Still rarer is its presentation as sclerosing cholangitis.
89 revealed a hierarchical pattern of spot sign presentations, as follows: A > B > C > D > no spot sign
90 third family had a similar but earlier-onset presentation associated with brain hypomyelination.
91        To characterize the incidence, types, presentations, associated factors, and outcomes of neona
92 ho underwent appendectomy within 24 hours of presentation at 23 children's hospitals from January 1,
93  from each participant, including phenotypic presentation at birth and disease course.
94 17/221 promoted beta1 integrin recycling and presentation back onto the surface of macrophages, in pa
95 ilding on a largely morphology- and clinical presentation-based strategy.
96  findings in the context of patient clinical presentations because accurate interpretation of pathoge
97       A third sibling also died of a similar presentation, but DNA was unavailable to confirm the mut
98 e that M. tuberculosis EsxL inhibits antigen presentation by enhancing H3K9me2/3 at the CIITA promote
99 ed with a marked inhibition in antigen cross-presentation by Igfbp7(-/-) dendritic cells.
100                              Peptide antigen presentation by major histocompatibility complex (MHC) c
101 first described as processors of antigen for presentation by major histocompatibility complex molecul
102  1, 2013, and March 31, 2014, 1647 self-harm presentations by 1153 patients were recorded.
103  change in voice, and dry skin, but clinical presentation can differ with age and sex, among other fa
104      The ability to recognize these variable presentations can be important for the diagnosis of TSC.
105                Recognition of these variable presentations can be important for TSC diagnosis.
106 , neutrophils consistently displayed antigen presentation capability.
107 FN-gamma-responsive genes related to antigen presentation, chemokine expression, cytotoxic activity,
108 pathways including those involved in antigen presentation, chemotaxis, innate and adaptive immunity a
109 ility of S. aureus, heterogeneity of disease presentation, clinical course, and outcome between indiv
110 e shorter delays from symptom development to presentation compared with women who had never undergone
111 h adenovirus, a model for intrahepatic cross-presentation, confirms hepatocytes directly contribute t
112 our data reveal a mechanism by which antigen presentation controls the innate effector function of Th
113 re the first record of 1 of 4 cardiovascular presentations (coronary heart disease [CHD], cerebrovasc
114  were divided into 2 groups based on date of presentation: decade 1 (1995-2005) and decade 2 (2006-20
115  retinitis involving >/=25% of the retina at presentation detached at nearly 12 times the rate, as co
116                   To expand understanding of presentation, diagnosis, and outcomes of hemorrhagic occ
117 ch as pathophysiology, patient demographics, presentation, diagnosis, treatment, and outcomes, were e
118 eal fetus in fetu and discusses its clinical presentation, differential diagnosis and embryologic ori
119 nown, and it is unclear whether the clinical presentation differs between patients positive for PLA2R
120 ved TAMs played more potent roles in antigen presentation, embryonically derived TAMs exhibited a pro
121                      The material chemistry, presentation, environmental conditions and testing metho
122 nalyze Sec61's contribution to antigen cross-presentation, ERAD, and transport of internalized antige
123     This review will give an overview of the presentation, evaluation, and treatment of immunocompete
124      DCs from these mice show impaired cross-presentation ex vivo and defective cross-priming of CD8(
125 he importance of the temporal pattern of Dpp presentation for morphogenesis of the wing.
126 pporting an impaired endocytic lipid antigen presentation for T cell activation upon benzo[a]pyrene e
127 hospital resource use and care costs for all presentations for self-harm to the John Radcliffe Hospit
128           Three working groups addressed the presentation format, the reference data supporting inter
129 ial Results, CardioSource, and abstracts and presentations from major cardiovascular meetings up to A
130 bMed and Embase and conference abstracts and presentations from the Conference on Retroviruses and Op
131 tem in ALS may translate into the split hand presentation, gait disturbance, split leg syndrome and b
132 y induce T-cell proliferation and an antigen presentation gene expression signature.
133  was associated with upregulation of antigen presentation genes, which correlated (r=0.78) with T-cel
134        In contrast, conditions of sequential presentation have been assumed to be free from competiti
135  Myocarditis was diagnosed based on clinical presentation, high-sensitivity troponin T, and cardiac m
136                                     Clinical presentations, histopathologic features, laboratory exam
137           Troponin concentrations <5 ng/L at presentation identified 17% of patients with renal impai
138 ad 20/40 (or equivalent) or better vision at presentation in at least 1 eye.
139 d we aimed at studying IgE-dependent antigen presentation in both cell types.
140 dy demonstrates a mechanism regulating cross-presentation in cancer and suggests potential therapeuti
141      We conclude that Sec22b-dependent cross-presentation in DCs is required to initiate CD8(+) T cel
142 using death, place of death, time from index presentation in last year of life to death, whether enro
143 reactivated with either i.v. or i.p. cocaine presentation in the absence of any cue.
144                                     Clinical presentation in three of the four patients is remarkably
145 nse by efficiently stimulating antigen cross-presentation in vivo and in vitro assessed by BMDC OT-I
146 ygdala and cortical areas to repeated threat presentations in a prospective study of PTSD.
147 till learning more about the myriad clinical presentations in these severely affected children, it is
148 n essential component of MHC class I antigen presentation, in 29.4% of patients with progressing dise
149  HspQ via a C-terminal degron, whose precise presentation, in synergy with multipartite contacts with
150                                         CASE PRESENTATION: In this vignette, we describe a 73 year-ol
151 owed that expression of mediators of antigen presentation, including MHC class I and beta2 microglobu
152 n of genes related to antigen processing and presentation, including the gene encoding the major hist
153 bilities with three main phenotypic clinical presentations, including logopenic, non-fluent/agrammati
154 CI: 1.07, 1.92; p = 0.016), with respiratory presentations increasing by 52% with fortified SQ-LNS (a
155 ve been associated with overlapping clinical presentations, indicating shared and distinct functions
156 ng that Sec61 blockade affects antigen cross-presentation indirectly.
157                                          Cue presentation induces retrieval of the drug-cue memory, w
158 ary syndrome and non-acute coronary syndrome presentations (interaction P=0.15).
159                                         CASE PRESENTATION: Intraoperative spectral domain optical coh
160  most significantly associated with clinical presentation: intrarenal polyomavirus load levels and Ba
161 -corrected visual acuity (BCVA) was 20/30 at presentation (IQR, 0.00-0.50) and remained at 20/30 thro
162                                        Cross-presentation is a critical function of dendritic cells (
163                             The mean time to presentation is approximately 10 years after implant pla
164                    More rarely, the clinical presentation is characterised by non-length-dependent, f
165                                   The visual presentation is intuitive and browsing is fluid, providi
166                                      Disease presentation is variable, often coinciding with loss of
167 a consortium aiming to describe the clinical presentation, management, and outcomes of patients with
168  an action, and yoked extinction, with shock presentation matched to the active condition, but withou
169 with the same disease and a similar clinical presentation may have very different outcomes and need v
170 last examination, 64.41 +/- 6.76 months from presentation, mean final VA was 20/283 (logMAR equivalen
171             We postulated that lipid antigen presentation mediated by cluster of differentiation 1 (C
172                     This increased E75 cross-presentation, mediated by trastuzumab treatment, enabled
173 cytokine module that, along with the antigen presentation module, promoted the generation of effector
174             Endocarditis was the most common presentation (n = 11).
175                            Within 2 years of presentation, normalization of function occurs in 20% of
176 linical, and echocardiographic data at first presentation of 1992 patients with BAV (71.5% men) were
177                                 The clinical presentation of a C. sativa allergy varies from mild to
178 clinical phenotype ranges from the classical presentation of a congenital myasthenic syndrome in one
179 ose-derived stem cells (hASCs), allowing the presentation of a continuous range of stiffnesses in a s
180 ensity EEG, we show that, already before the presentation of a critical word, context-induced semanti
181 sker response amplitude is also modulated by presentation of a movie recreating the mouse's visual ex
182                            Accordingly, poor presentation of a mutation across patients was correlate
183                     Here we demonstrate that presentation of a novel visual stimulus (a single orient
184 a that shows increased c-Fos expression upon presentation of a sour tastant (30 mM citric acid).
185  These findings are relevant to the clinical presentation of acetaminophen-hepatotoxicity and may inf
186 ow Ragulator functions as a platform for the presentation of active Rags for mTORC1 recruitment, and
187 nventional retinotopic mapping with episodic presentation of adjacent stimuli, a continuous, periodic
188  a cancer diagnosis, understand the clinical presentation of adult patients with cancer in the ED, an
189 rms hepatocytes directly contribute to cross-presentation of Ags and priming the pool of naive CD8(+)
190 an trace conditioning procedure in which the presentation of an auditory cue and food were separated
191 al autophagy, key processes that control the presentation of antigens by dendritic cells (DCs) to nai
192 y, consistent with their defect in the cross-presentation of apoptotic cells, DC-specific Vps34-defic
193 aper, we aimed to report an atypical imaging presentation of CPAM type II in the second trimester, ex
194  two complementary theories that explain the presentation of disease symptoms on the basis of changes
195  a combination of factors, including earlier presentation of disease, fewer eyes being observed witho
196 tructive to productive and facilitates cross-presentation of disease-relevant epitopes to CD8(+) T ce
197 ven when the non-rest condition includes the presentation of emotional provoking stimuli, particularl
198 od, patient age and multi-morbidity at first presentation of heart failure increased (mean age 76.5 y
199                   Our model predicts surface presentation of HIV peptides over time, demonstrates the
200 e and evolution of clinical and pathological presentation of HIV-associated neurocognitive disorders
201 transcription factor Foxp3 in T cells, trans-presentation of IL-6 by DC-bound IL-6Ralpha (called 'IL-
202  present study we investigated Ag uptake and presentation of in vivo-formed Ag-Ab complexes by i.v. i
203  in clinical practice as well as the diverse presentation of intestinal melanoma metastases and the d
204                                              Presentation of magnetic resonance imaging (MRI) finding
205  by trypanosomes and are associated with the presentation of neurological disturbances independently
206 nfirmation of previously described genes and presentation of novel candidates and provide an overview
207  to the ASCO membership after publication or presentation of potential practice-changing data.
208 luding breast cancer, which results in cross-presentation of PR1, an NE-derived HLA-A2-restricted pep
209 sion injury also promoted DC-dependent cross-presentation of renal antigens to CD8 T cells in the dra
210 racranial recordings and visual word-by-word presentation of sentences and word lists to investigate
211 utations of pattern separation to subsequent presentation of similar stimuli.SIGNIFICANCE STATEMENT T
212                              The multivalent presentation of specific carbohydrates by using 3D fulle
213 s other than breast cancer prior to clinical presentation of that cancer, for ductal carcinoma in sit
214 paration of the prediction interval from the presentation of the final sentence item.
215 emical inhibition of Usp14 diminished direct presentation of the model antigenic peptide, and the eff
216 tem cell cultures do not control the spatial presentation of the protein.
217 al cells (TECs) through their expression and presentation of tissue-specific Ags to developing thymoc
218 nt biological or neural damage, (b) to avoid presentation of uncomfortably loud sounds, and (c) to en
219 e and prolonged duration, implying prolonged presentation of viral antigens.
220 ds, beginning prior to water ingestion, upon presentation of water-predicting cues.
221 ly healthy obese individuals and 4 different presentations of incident cardiovascular disease in a co
222 ably diagnose the whole spectrum of clinical presentations of PJI.
223   New research criteria that recognise early presentations of PSP and operationalise diagnosis of the
224           There are 2 predominate phenotypic presentations of the disease: transthyretin familial amy
225 t different choices when faced with repeated presentations of the same evidence.
226 eremia), in patients at the time of clinical presentation on IL-10 production and its association wit
227 drates and the diverse array of carbohydrate presentations on the cell surface.
228       Further understanding of risk factors, presentation, optimal management of, and screening for u
229 the CS and during the ISI, but not during US presentations or in the ITI) after infusion in mPFC, whe
230 genes that are more associated with clinical presentations or other genotypic markers.
231 F]FEPPA VT and duration of illness, clinical presentation, or neuropsychological measures after adjus
232 tic biomolecules often result in short-lived presentations, or require genetic manipulation to facili
233 onsider duration range, number of trials and presentation order as crucial factors modulating perform
234   Our results constitute the first report of presentation order effects in the Episodic Temporal Gene
235 results are scale-free and unaffected by the presentation order of the stimuli.
236 determine the association of gender with the presentation, outcome, and host response in critically i
237  present across the entire period of patient presentation, particularly in those experiencing a secon
238  is the single most selective step in the Ag-presentation pathway.
239 ate that functional Usp14 enhances direct Ag presentation, preferentially of DRiP-derived peptides, s
240 l age at birth, birthweight, stage of ROP at presentation, prior treatment (laser or cryotherapy), su
241                                     Clinical presentations range from self-limited disease to severe
242                 Rats learned to increase the presentation rate of the selected theta to beta-gamma (t
243 ants' performance improved with asynchronous presentation relative to synchronous - temporal ventrilo
244 and challenge the assumption that sequential presentation removes competition.
245                                 The clinical presentation runs a spectrum, ranging from headache and
246 eloped and applied a residue-centric patient presentation score to 9,176 cancer patients across 1,018
247  of cortical activity before and during tone presentation shows that these changes in evoked and spon
248                                Additionally, presentation specifically from DRiP Ags was diminished b
249                                     The "For Presentation" standard-dose mammograms and synthetic ima
250  contribution of factors critical to epitope presentation, such as protein cleavage and gene expressi
251 atter progressively increased after clinical presentation, suggesting not only a failure of age-expec
252  Genetic cases were significantly younger at presentation than Clinical cases (40.6+/-12.5 vs. 47.5+/
253 n discovered to have impaired vision, with a presentation that resembles syndromes of elevated intrac
254   The more arterial the pattern of spot sign presentation, the greater the frequency of substantial h
255  reward-based effects required long stimulus presentation, the influence of contrast was strongest wi
256                                           At presentation, the mean tumor thickness was 3.39 mm (rang
257                            With simultaneous presentation, the measure of WM precision was significan
258                                   At initial presentation, the median CTG expansion size was 530 (int
259  was the odds of discharge within 6 hours of presentation There were 11 529 participants in the preim
260 w report that ImmunoCloak interrupts antigen presentation thereby preventing early T cell activation
261                However, in those with severe presentations, this proportional recovery applies in onl
262 and 55 (38.2%) visually impaired patients at presentation to 2 (1.4%) and 5 (3.5%) patients respectiv
263                    Endogenous myelin peptide presentation to CD4(+) T cells following phagocytosis of
264              Primary outcomes were time from presentation to documentation of symptom resolution and
265 ake a pragmatic comparison of the risk of re-presentation to hospital with vivax malaria in patients
266 nfirmed EVD had similar Ebola viral loads on presentation to nonpregnant women, as measured by initia
267 erbation of symptoms within 2 years of first presentation to psychiatric services.
268 ore, this system allows for LC-restricted Ag presentation to T cells.
269 nation of three standard criteria including: presentation to the emergency department for medical car
270 nal end of this epitope dramatically improve presentation to these T cells.
271 rent knowledge of the epidemiology, clinical presentation, treatment, and pathogenesis of these tumor
272 urther on to humans, and the severe clinical presentation typical in these latter incidental hosts.
273 of T cells stimulated by IL-2 and by antigen presentation using a Theileria-transformed cell line and
274                                     Clinical presentation varied with age but not by serotypes in the
275                                  Mean age at presentation was 41.8 (range 3.3-81.6) years.
276     Delay of appendectomy within 24 hours of presentation was not associated with increased risk of c
277 sol, suggesting that the inhibition of cross-presentation was not related to either of these traffick
278 A trend toward an increased bleeding rate at presentation was observed in HHT (p = 0.069) and an incr
279 nd the effect was especially pronounced when presentation was restricted to the defective ribosomal p
280                                 Through this presentation we show the remarkable similarities and dif
281                                         CASE PRESENTATION: We present a 51-years-old woman with relev
282                                         CASE PRESENTATIONS: We report on two siblings with KS.
283 matter (GM) and white matter (WM) atrophy at presentation were assessed and tested as predictors of p
284  with cardiogenic shock or cardiac arrest on presentation were excluded.
285 he risk stratification threshold (5 ng/L) at presentation were reported for a primary outcome of inde
286        Numbers of ambulatory and ED diplopia presentations were estimated using weighted sample data.
287                                   1150 (70%) presentations were for self-poisoning alone, 367 (22%) f
288 esulted in both higher and prolonged antigen presentation when compared to disulfide-linked peptide.
289     The mean time from surgical procedure to presentation with endophthalmitis was 6.8 months (range:
290 than 23% as a measure of hydration status at presentation with HUS was associated with the developmen
291                               The risk of re-presentation with P. vivax malaria was higher in childre
292                       This delay between the presentation with symptoms and the ability to make an in
293                                              Presentation with ulcer or gangrene, age >/=65 years, fe
294                               The risk of re-presentation with vivax malaria within 1 year was 33.8%
295  CABG over PCI no longer varied by acuity of presentation, with a hazard ratio for MACCE in ACS patie
296 rganisms can be optimized by manipulating Ag presentation, with implications for vaccine design.
297 harbor high-risk histopathologic features at presentation, with the absence of vitreous seeds being a
298 sing of Gag can lead to a 50% probability of presentation within 3 hours post-infection, as observed
299 EFE, as patients are typically ambulatory on presentation without systemic signs of infection.
300               We hypothesized that the rapid presentation would reduce salience (the sudden appearanc

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top